Cargando…
Immunomodulation: The next target of mesenchymal stem cell-derived exosomes in the context of ischemic stroke
Ischemic stroke (IS) is the most prevalent form of brain disease, characterized by high morbidity, disability, and mortality. However, there is still a lack of ideal prevention and treatment measures in clinical practice. Notably, the transplantation therapy of mesenchymal stem cells (MSCs) has been...
Autores principales: | Shan, Xiao-Qian, Luo, Yong-Yin, Chang, Jun, Song, Jing-Jing, Hao, Nan, Zhao, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052343/ https://www.ncbi.nlm.nih.gov/pubmed/37007453 http://dx.doi.org/10.4252/wjsc.v15.i3.52 |
Ejemplares similares
-
Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?
por: Willis, Gareth R., et al.
Publicado: (2018) -
Exosomes Derived From Mesenchymal Stem Cells: Novel Effects in the Treatment of Ischemic Stroke
por: Xiong, Yu, et al.
Publicado: (2022) -
Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?
por: Kou, Meng, et al.
Publicado: (2022) -
In vivo Monitoring and Assessment of Exogenous Mesenchymal Stem Cell-Derived Exosomes in Mice with Ischemic Stroke by Molecular Imaging
por: Xu, Rong, et al.
Publicado: (2020) -
Exosomes from bone marrow mesenchymal stem cells are a potential treatment for ischemic stroke
por: Liu, Chang, et al.
Publicado: (2023)